| Phase 4 |
| NCT06683131 |
Effectiveness of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor… |
Acute Myocardial Infarction (AMI) |
Not Yet Recruiting |
| Phase 3 |
| NCT07098897 |
To Evaluate the Effect and Safety of Telitacicept and Standard Treatment for 6months in… |
IgA Nephropathy (IgAN) |
Active, Not Recruiting |
| Phase 2 |
| NCT07058103 |
Tislelizumab , Cyclophosphamide, Mitoxantrone Liposomes, Chidamide, and Prednisone in the… |
Angioimmunoblastic T-Cell Lymphoma Recurrent |
Recruiting |
| NCT07168317 |
Tislelizumab , Cyclophosphamide, Mitoxantrone Liposomes, Chidamide, and Prednisone in the… |
New Diagnosed Angioimmunoblastic T-Cell Lymphoma |
Recruiting |
| NCT07680933 |
Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous… |
DLBCL - Diffuse Large B Cell Lymphoma |
Recruiting |
| NCT06958484 |
Iparomlimab and Tuvonralimab Injection (QL1706) Combined With Bevacizumab for… |
HCC - Hepatocellular Carcinoma |
Not Yet Recruiting |
| Phase 1/2 |
| NCT05211557 |
Study of Fully Human B7H3 CAR-T in Treating Recurrent Malignant Ovarian Cancer |
Ovarian Cancer |
Recruiting |
| NCT05323201 |
Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer |
Hepatocellular Carcinoma |
Recruiting |
| NCT07133763 |
Application of PD-1 Inhibitors, Tenofovir, Chidamide, and Lenalidomide in… |
EBV-Associated Lymphoproliferative Disorders |
Not Yet Recruiting |
| NCT07133776 |
Application of PD-1 Inhibitors Combined With Tenofovir, Chidamide and Lenalidomide in the… |
Epstein-Barr Virus (EBV) Infection |
Not Yet Recruiting |
| Phase 1 |
| NCT04969354 |
Clinical Study of CAIX-targeted CAR-T Cells in the Treatment of Advanced Renal Cell… |
Immunotherapy |
Recruiting |
| NCT05354375 |
Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant… |
Immunotherapy |
Recruiting |
| NCT06632964 |
A Clinical Trial Aimed at Assessing the Efficacy and Safety of VT-101 for the Treatment… |
Non-muscle Invasive Bladder Cancer |
Recruiting |
| NCT07285395 |
AT1019 Plus SBRT and PD-1 Inhibitor for Advanced Solid Tumors: An IIT Study |
Advanced Solid Tumors |
Recruiting |
| Early Phase 1 |
| NCT06104215 |
BGT007H Cells for the Treatment of Refractory Digestive System Tumors |
Digestive Tract Cancer |
Recruiting |
| NCT06104241 |
BGT007 Cells for the Treatment of Refractory Digestive System Tumors |
Gastrointestinal Cancer |
Recruiting |
| NCT07546110 |
An Open-Label, Single-Arm Clinical Study to Evaluate the Safety and Preliminary Efficacy… |
Multiple Sclerosis |
Not Yet Recruiting |
| Not specified |
| NCT06277466 |
Effect of Mutations in T2DM Susceptibility Genes on the Expression of Susceptibility… |
Type 2 Diabetes Mellitus |
Recruiting |
| NCT06268262 |
Surgical-imaging Research on Obesity (SIRO) |
Overweight and Obesity |
Recruiting |
| NCT05098340 |
Circulating circRNA in Acute Ischemic Stroke |
Acute Ischemic Stroke |
Recruiting |
| NCT06545591 |
Predictive Role of sTREM in Endovascular Thrombectomy Outcomes |
Acute Ischemic Stroke |
Recruiting |
| NCT06614998 |
Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis… |
Hemophagocytic Syndrome |
Recruiting |
| NCT07120633 |
Anti CD19 CAR-T Combined With BTKi to Treat Newly Diagnosed High-risk CLL/SLL |
CLL |
Recruiting |
| NCT06256419 |
Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic… |
Type 2 Diabetes Mellitus |
Recruiting |
| NCT07413835 |
Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG) |
Refractory Myasthenia Gravis |
Recruiting |